EMCDDA Management Board renews mandate of Alexis Goosdeel
The EMCDDA Management Board took the unanimous decision today to renew the mandate of the agency’s Director, Alexis Goosdeel, for the next five years. Mr Goosdeel took up the post of EMCDDA Director on 1 January 2016 and will now hold the position until 31 December 2025.
COVID-19: New EMCDDA study highlights decline in stimulant drug use but some rises in the use of cannabis, alcohol and prescription medicines to combat anxiety and depression
A decline in stimulant drug use but some rises in the consumption of cannabis and licit substances are among the findings presented today in a new EMCDDA report The impact of COVID-19 on patterns of drug use an
New Zealand: referendum on cannabis legalisation to take place in September 2020
Following an agreement made in 2017 between the ruling coalition parties in New Zealand, it has been announced that a referendum on legalising the recreational use of cannabis will be held together with the next general election, on 19 September 2020.
Increase in darknet market activity for cannabis as users stock up for lockdown
The COVID-19 pandemic has profoundly impacted on our daily lives, including our behaviour as consumers. Just as we have seen online shopping for other goods increase during lockdowns, will we see a similar shift when it comes to illicit drugs?
EMCDDA launches COVID-19 special round of European Web Survey on Drugs to assess impact of pandemic
Crucial information on the impact of COVID-19 on people who use drugs, and on the services that support them, will be collected via a special round of the European Web Survey on Drugs, launched this week.
25 years of monitoring — selected events from the EMCDDA’s international cooperation history
Drugs have long been a cross-border phenomenon. As drug problems in Europe are increasingly linked to, and influenced by, global developments, it is crucial that our analysis of trends and developments be placed in the wider international context.
EMCDDA publishes update on the implications of COVID-19 for people who use drugs and for drug service providers
What specific risks are people who use drugs (PWUD) likely to face during the COVID-19 pandemic? What services will they need? How will professionals working with this group need to adapt on the frontline? These are among the questions raised in a new EMCDDA update published today.
EMCDDA offers its sympathies to earthquake-struck Croatia
A large earthquake rocked Croatian capital Zagreb on 22 March, increasing the strain on the country’s emergency services, which are already challenged by the COVID-19 pandemic. The EMCDDA offers its solidarity to Croatia, in particular to the country’s Rei
New COVID-19 precautionary measures: EMCDDA to switch to teleworking from 16 March 2020
EMCDDA staff members will be switching to teleworking today following a decision by its Director Alexis Goosdeel (1). The decision comes as the COVID-19 pandemic continues to intensify and as the EU and its Member States adopt new precautionary measures.
Latest wastewater data reveal drug-taking habits in 68 European cities — traces of stimulant drugs rise again
The latest findings from the largest European project in the emerging science of wastewater analysis are presented today by the Europe-wide SCORE group, in association with the EU drugs agency (EMCDDA) (1). The project analysed waste
Bursaries for Western Balkan students for the 2020 European Drugs Summer School
Professionals, academics and experts from the Western Balkan region will have an opportunity to participate in the European Drugs Summer School (EDSS) this year, thanks to three bursaries being offered through the EMCDDA Instrum